GlassScriptPhysician profile
Jonathan Henry Demeter
NPI 1063944536
$8,184.24
in general payments reported to CMS, 2019-2025
39 companies · $2,382 in 2025
The $2,382 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.40 · 2020: $89.96 · 2021: $140 · 2022: $1,516 · 2023: $1,784 · 2024: $2,201 · 2025: $2,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,244 · Travel and Lodging: $861 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,243.89 |
| Travel and Lodging | $860.66 |
| Education | $263.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,381.35 | 2022-2024 | Urolift |
| Axonics, INC. | $878.06 | 2022-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $828.52 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $645.79 | 2022-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $634.46 | 2019-2025 | Lithovue, Moses 550 Dfl, Rezum Generator |
| Janssen Biotech, INC. | $601.81 | 2022-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $488.95 | 2022-2025 | |
| Pfizer INC. | $318.22 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $294.69 | 2023-2025 | Provenge |
| Accord Healthcare, INC. | $252.17 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $245.18 | 2023-2025 | Orgovyx |
| Urogen Pharma, INC. | $172.13 | 2022-2025 | Jelmyto |
| Coloplast Corp | $151.28 | 2020-2024 | Speedicath |
| Ferring Pharmaceuticals INC. | $133.48 | 2024-2025 | Adstiladrin |
| Antares Pharma, INC. | $132.96 | 2023-2025 | Xyosted, Tlando, Nocdurna |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $105.12 | 2025 | |
| Endo USA, INC. | $97.63 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $71.40 | 2024-2025 | Itind System, Soltive |
| Progenics Pharmaceuticals, INC. | $59.65 | 2023-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $58.10 | 2022-2023 | Xiaflex, Aveed |
| 180 Medical, INC. | $57.18 | 2022-2023 | |
| Valencia Technologies Corporation | $54.11 | 2025 | Ecoin Device Kit |
| Azurity Pharmaceuticals, INC. | $48.80 | 2025 | Azmiro |
| Merck Sharp & Dohme LLC | $45.32 | 2024-2025 | Keytruda, Keytruda Qlex |
| Cook Medical LLC | $44.97 | 2024-2025 | Resonance |
| Integra Lifesciences Corporation | $36.21 | 2022 | |
| Amgen INC. | $36.01 | 2023-2024 | Xgeva, Evenity, Prolia |
| Verity Pharmaceuticals INC. | $31.78 | 2024-2025 | Trelstar |
| Tolmar, INC. | $31.13 | 2024-2025 | Jatenzo, Eligard |
| Tempus Ai, INC | $29.53 | 2024 | |
| Laborie Medical Technologies Corp. | $27.84 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $26.84 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $26.36 | 2023 | Seglentis |
| Biotissue Holdings INC. | $24.38 | 2022 | |
| Innovation Technologies INC | $24.02 | 2024 | Irrisept |
| Blue Earth Diagnostics | $23.74 | 2024 | |
| Myovant Sciences INC. | $23.54 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $22.16 | 2023 | Lynparza |
| Civco Medical Instruments | $19.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Demeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.